Inactivation of Gram-negative and Gram-positive bacteria in red cell concentrates using INACTINE PEN110 chemistry

Vox Sanguinis

Volumn 87, Issue 3, 2004, Pages 143-149

  Zavizion, B ^a   Serebryanik, D ^a   Chapman, J ^a   Alford, B ^a   Purmal, A ^a  

^a VI Technologies Inc   (United States)

Author keywords

Bacteria; INACTINE; Pathogen inactivation; PEN110; Red cell concentrate

Indexed keywords

INACTINE; MOLECULE TRANSPORT AGENT; PEN110; UNCLASSIFIED DRUG;

ACINETOBACTER; ACINETOBACTER JOHNSONII; ACINETOBACTER LWOFFII; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL VIABILITY; BACTERIOSTASIS; BACTERIUM TITER; BLOOD STORAGE; BLOOD TRANSFUSION; CELL VIABILITY; CHEMICAL PROCEDURES; CLOSTRIDIUM PERFRINGENS; COLONY FORMING UNIT; CONTROLLED STUDY; CRYOPRESERVATION; CULTURE MEDIUM; DOSE TIME EFFECT RELATION; ERYTHROCYTE CONCENTRATE; EUROPE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES;

ACINETOBACTER; BACTEREMIA; CLOSTRIDIUM PERFRINGENS; COLONY COUNT, MICROBIAL; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; POLYAMINES; PROPIONIBACTERIUM ACNES; SAFETY;

EID: 7944223376     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2004.00556.x     Document Type: Article

References (29)

1. Soeterboek AM, Welle FH, Marcelis JH, Jansz A, van der Loop CM: Prevalence of bacterial contamination in whole blood after donation. Vox Sang 1995; 69:149
2. Blajchman MA: Bacterial contamination and proliferation during the storage of cellular blood products. Vox Sang 1998; 74:155-159
3. Kuehnert MJ, Roth VR, Haley NR, Gregory KR, Elder KV, Schreiber GB, Arduino MJ, Holt SC, Carson LA, Banerjee SN, Jarvis WR: Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 2001; 41:1493-1499
4. Perez P, Salmi LR, Follea G, Schmit JL, de Barbeyrac B, Sudre P, Salamon R: Determinants of transfusion-associated bacterial contamination: results of the French BACTHEM Case-Control Study. Transfusion 2001; 41:862-872
5. Reading FC, Brecher ME: Transfusion-related bacterial sepsis. Curr Opin Hematol 2001; 8:380-386
6. Blajchman MA: Incidence and significance of the bacterial contamination of blood components. Dev Biol (Basel) 2002; 108:59-67
7. Murphy WG: Disease transmission by blood products: past, present and future. Pathophysiol Haemost Thromb 2002; 32:1-4
8. Dinse H, Deusch H: Sepsis following autologous blood transfusion. Anaesthesist 1996; 45:460-463
9. Sazama K: Bacteria in blood for transfusion. Arch Pathol Lab Med 1994; 118:350-365
10. Engelfriet CP, Reesink HW, Blajchman MA, Muyelle L, Kjeldsen-Kragh J, Kekomaki R, Yomtorian R, Hocker P, Stiegler G, Klein HG, Soldan K, Barbara J, Slopecki A, Robinson A, Seyfried H: International Forum: Bacterial contamination of blood components. Vox Sang 2000; 78:59-67
11. Hatheway CL: Toxigenic clostridia. Clin Microbiol Rev 1990; 3:66-98
12. de Korte D, Marcelis JH, Soeterboek AM: Determination of the degree of bacterial contamination of whole-blood collections using an automated microbe-detection system. Transfusion 2001; 41:815-818
13. Berlau J, Aucken H, Malnick H, Pitt T: Distribution of Acinetobacter species on skin of healthy humans. Eur J Clin Microbiol Infect Dis 1999; 18:179-183
14. Seifert H, Dijkshoorn L, Gerner-Smidt P, Pelzer N, Tjernberg I, Vaneechoutte M: Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J Clin Microbiol 1997; 35:2819-2825
15. Zavizion B, Serebryanik D, Serebryanik I, Chapman J, Purmal A: Prevention of Yersinia enterocolitica, Pseudomonas fluorescens, and Pseudomonas putida outgrowth in deliberately inoculated blood by a novel pathogen-reduction process. Transfusion 2003; 43:135-142
16. Lazo A, Tassello J, Jayarama J, Ohagen A, Gibaja V, Kramer E, Marmorato A, Billia-Shaveet D, Purmal A, Brown F, Chapman J: A broad spectrum virus reduction in red cell concentrates using INACTINE™ PEN110 chemistry. Vox Sang 2002; 83:313-323
17. Zavizion B, Pereira M, Jorge MM, Serebryanik D, Mather TN, Chapman J, Miller NJ, Alford B, Bzik DJ, Purmal A: Inactivation of protozoan parasites in red cells using INACTINE PEN110 chemistry. Transfusion 2004; 44:731-738
18. Fast LD, DiLeone G, Edson CM, Purmal A: PEN110 treatment functionally inactivates the PBMNCs present in RBC units: comparison to the effects of exposure to gamma irradiation. Transfusion 2002; 42:1318-1325
19. Hemminki K: Reactions of ethyleneimine with guanosine and deoxyguanosine. Chem Biol Interact 1984; 48:249-260
20. Budowsky EI, Zalesskaya MA, Nepomnyashchaya NM, Kostyanovsky RG: Principals of selective inactivation of the viral genome: dependence of the rate of viral RNA modification on the number of protonizable groups in ethyleneimine oligomers. Vaccine Res 1996; 5:29-39
21. O'Connor TR, Boiteux S, Laval J: Ring-open 7-methylguanine residues are a block to in vitro DNA synthesis. Nucleic Acids Res 1988; 16:5879-5894
22. Hogman CF, Gong J, Eriksson L, Hambraeus A, Johansson CS: White cells protect donor blood against bacterial contamination. Transfusion 1991; 31:620-626
23. Dzik WH: Leukoreduction of blood components. Curr Opin Hematol 2002; 9:521-526
24. McDonald CP, Lowe P, Roy A, Robbins S, Hartley S, Harrison JF, Slopecki A, Verlander N, Barbara JA: Evaluation of donor arm disinfection techniques. Vox Sang 2001; 80:135-141
25. Bruneau C, Perez P, Chassaigne M, Allouch P, Audurier A, Gulian C, Janus G, Boulard G, De Micco P, Salmi LR, Noel L: Efficacy of a new collection procedure for preventing bacterial contamination of whole-blood donations. Transfusion 2001; 41:74-81
26. Zavizion B, Purmal A, Chapman J, Alford B: Inactivation of mycoplasma species in blood by INACTINE™ PEN110 process. Transfusion 2004; 44:286-293
27. Zavizion B, Serebryanik D, Purmal A: Collection system equivalency using the PEN110 pathogen reduction process for pathogen inactivation: bacterial inactivation assessment. Transfusion 2001; 41:89S
28. Purmal A, Valeri CR, Dzik W, Pivacek L, Ragno G, Lazo A, Chapman J: Process for the preparation of pathogen-inactivated RBC concentrates by using PEN110 chemistry: preclinical studies. Transfusion 2002; 42:139-145
29. AuBuchon JP, Pickard CA, Hershel LH, Roger JC, Tracy JE, Purmal A, Chapman J, Ackerman S, Beach KJ: Production of pathogen-inactivated RBC concentrates using PEN110 chemistry: a Phase I clinical study. Transfusion 2002; 42:146-152